Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma

出版年份 2016 全文链接

标题

作者

关键词

Renal cell carcinoma, anti-angiogenic therapy, ALK-1, VEGF, Dalantercept

出版物

Volume 7, Issue 27, Pages -

出版商

Impact Journals, LLC

发表日期

2016-05-26

DOI

10.18632/oncotarget.9621

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started